Skip to content
Toggle main navigation
About
About TEPHINET
About TEPHIConnect
Terms of Use and Privacy
How to Join
Why Join?
News
Events
Groups
Journals
BMC Medicine
BMC Medical Research Methodology
Clinical Epidemiology and Global Health
Emerging Microbes & Infections
Frontiers in Epidemiology
Global Health Journal
International Journal of Epidemiology
Online Library Journal
PLoS One
Science Direct Journal (Global Health)
Science Direct Journal (Clinical Epidemiology and Global Health)
More
Open dropdown to see remaining menu items
Log in
Request to join
Notice to Readers: Change in Publication Date of MMWR Series
Published on January 11, 2024
Notice to Readers: Change in Publication Date of MMWR Series
Continue reading on website
Other news
Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial
January 10, 2024
BackgroundIn the COVID-STEROID 2 trial there was suggestion of heterogeneity of treatment effects (HTE) between patients enrolled from Europe vs. India on the primary outcome. Whether there was HTE for the remaining patient-centred outcomes is unclear.MethodsIn this post hoc analysis of the COVID-STEROID 2 trial, which compared 12 mg vs. 6 mg dexamethasone in adults with COVID-19 and severe hypoxe
Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination
January 16, 2024
BackgroundTwo new products for preventing Respiratory Syncytial Virus (RSV) in young children have been licensed: a single-dose long-acting monoclonal antibody (la-mAB) and a maternal vaccine (MV). To facilitate the selection of new RSV intervention programmes for large-scale implementation, this study provides an assessment to compare the costs of potential programmes with the health benefits acc